February 15, 2019

FDA Panel Recommends Approval of Ketamine for Depression

A new drug developed by Johnson & Johnson named Esketamine may become the first new treatment in years for depression.  An expert panel composed of psychiatrists and consumer representatives was nearly unanimous in recommending that the FDA approve a nasal spray that delivers the active ingredient ketamine.  (more…)
Read More
February 8, 2019

New Hope for Cleaning Up Our Oceans?

Plastic is ubiquitous in our society, it is one of the most useful classes of materials we utilize in our everyday lives, and we are surrounded by it on more ways than one.  (more…)
Read More